Full Press Release Details
argenx announces full exercise of underwriters’ option to purchase additional ADSs.
ARGX
argenx announces full exercise of underwriters’ option to purchase additional ADSs
Key Takeaway: argenx announces full exercise of underwriters’ option to purchase additional ADSs
Price reaction · baseline $506.52 (2023-07-18 close) · hit after-hours · 1 other ARGX headline(s) in the window, move may be shared
day 0 close · peak
+4.3%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+36%
120-day peak, hindsight
Typical move
4.7%
average across 12 past catalysts
Lead asset
Empasiprubart
Phase 2 · AChR-Ab Seropositive Generalized Myasthenia Gravis